{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:28:45Z","timestamp":1785803325476,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00210-024-03294-2","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T06:02:41Z","timestamp":1721800961000},"page":"687-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patterns, outcomes, and preventability of clinically manifest drug-drug interactions in older outpatients: a subgroup analysis from a 6-year-long observational study in North India"],"prefix":"10.1007","volume":"398","author":[{"given":"Upinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaideep","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noti Taruni Srija","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajeet Singh","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankha Shubhra","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"3294_CR1","doi-asserted-by":"publisher","unstructured":"Charlton M, Thompson JP (2019) Pharmacokinetics in Sepsis. BJA Educ 19:7\u201313. https:\/\/doi.org\/10.1016\/j.bjae.2018.09.006","DOI":"10.1016\/j.bjae.2018.09.006"},{"key":"3294_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/pds.3592","volume":"23","author":"S Dechanont","year":"2014","unstructured":"Dechanont S, Maphanta S, Butthum B, Kongkaew C (2014) Hospital admissions\/visits associated with drug\u2013drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 23:489\u2013497. https:\/\/doi.org\/10.1002\/pds.3592","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3294_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/ejhpharm-2019-002111","volume":"28","author":"LM de Oliveira","year":"2021","unstructured":"de Oliveira LM, Diel JDAC, Nunes A, da Silva Dal Pizzol T, (2021) Prevalence of drug interactions in hospitalised elderly patients: a systematic review. Eur J Hosp Pharm 28:4\u20139. https:\/\/doi.org\/10.1136\/ejhpharm-2019-002111","journal-title":"Eur J Hosp Pharm"},{"key":"3294_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. The Lancet 356:1255\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(00)02799-9","journal-title":"The Lancet"},{"key":"3294_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","volume":"31","author":"M Franceschi","year":"2008","unstructured":"Franceschi M, Scarcelli C, Niro V et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit. Drug Saf 31:545\u2013556. https:\/\/doi.org\/10.2165\/00002018-200831060-00009","journal-title":"Drug Saf"},{"key":"3294_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/17425255.2020.1750597","volume":"16","author":"M Fujii","year":"2020","unstructured":"Fujii M, Karumai T, Yamamoto R et al (2020) Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis. Expert Opin Drug Metab Toxicol 16:415\u2013430. https:\/\/doi.org\/10.1080\/17425255.2020.1750597","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3294_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR et al (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107. https:\/\/doi.org\/10.1001\/jama.289.9.1107","journal-title":"JAMA"},{"key":"3294_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00228-016-2084-3","volume":"72","author":"M Gustafsson","year":"2016","unstructured":"Gustafsson M, Sj\u00f6lander M, Pfister B et al (2016) Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol 72:1143\u20131153. https:\/\/doi.org\/10.1007\/s00228-016-2084-3","journal-title":"Eur J Clin Pharmacol"},{"key":"3294_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF et al (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228:83\u201390. https:\/\/doi.org\/10.1111\/j.1365-2796.1990.tb00199.x","journal-title":"J Intern Med"},{"key":"3294_CR10","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ (1992) Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49:2229\u20132232","journal-title":"Am J Hosp Pharm"},{"key":"3294_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40266-022-01001-5","volume":"40","author":"JE Hughes","year":"2023","unstructured":"Hughes JE, Waldron C, Bennett KE, Cahir C (2023) Prevalence of drug\u2013drug interactions in older community-dwelling individuals: a systematic review and meta-analysis. Drugs Aging 40:117\u2013134. https:\/\/doi.org\/10.1007\/s40266-022-01001-5","journal-title":"Drugs Aging"},{"key":"3294_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247354","volume":"16","author":"S Jeong","year":"2021","unstructured":"Jeong S, Cho H, Kim YJ et al (2021) Drug-induced Parkinsonism: a strong predictor of idiopathic Parkinson\u2019s disease. PLoS ONE 16:e0247354. https:\/\/doi.org\/10.1371\/journal.pone.0247354","journal-title":"PLoS ONE"},{"key":"3294_CR13","doi-asserted-by":"publisher","unstructured":"Jiang H, Lin Y, Ren W et al (2022) Adverse drug reactions and correlations with drug\u2013drug interactions: a retrospective study of reports from 2011 to 2020. Front Pharmacol 13:923939. https:\/\/doi.org\/10.3389\/fphar.2022.923939","DOI":"10.3389\/fphar.2022.923939"},{"key":"3294_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S1041610223000807","volume":"35","author":"U Kaur","year":"2023","unstructured":"Kaur U, Chakrabarti SS, Reddy J et al (2023) Patterns and determinants of drug-related neurological problems in older outpatients: an exploratory analysis of a six-year long observational study in North India. Int Psychogeriatr 35:673\u2013676. https:\/\/doi.org\/10.1017\/S1041610223000807","journal-title":"Int Psychogeriatr"},{"key":"3294_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/ggi.14650","volume":"24","author":"U Kaur","year":"2024","unstructured":"Kaur U, Chakrabarti SS, Gupta GK et al (2024) Drug-related problems in older adults in outpatient settings: results from a 6-year long prospective study in a tertiary hospital of north India. Geriatr Gerontol Int 24:285\u2013291. https:\/\/doi.org\/10.1111\/ggi.14650","journal-title":"Geriatr Gerontol Int"},{"key":"3294_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14740338.2016.1221400","volume":"15","author":"A Marino","year":"2016","unstructured":"Marino A, Capogrosso-Sansone A, Tuccori M et al (2016) Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study. Expert Opin Drug Saf 15:45\u201350. https:\/\/doi.org\/10.1080\/14740338.2016.1221400","journal-title":"Expert Opin Drug Saf"},{"key":"3294_CR17","unstructured":"Medical dictionary for regulatory activities MedDRA Hierarchy (MedDRA) (2019)\u00a0https:\/\/www.meddra.org\/.\u00a0Accessed 10 May 2024"},{"key":"3294_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2710.2009.01021.x","volume":"34","author":"A Nobili","year":"2009","unstructured":"Nobili A, Pasina L, Tettamanti M et al (2009) Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 34:377\u2013386. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01021.x","journal-title":"J Clin Pharm Ther"},{"key":"3294_CR19","doi-asserted-by":"publisher","unstructured":"O\u010dovsk\u00e1 Z, Ma\u0159\u00edkov\u00e1 M, Vl\u010dek J (2023) Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: a cross-sectional study. Front Pharmacol 14:1088900. https:\/\/doi.org\/10.3389\/fphar.2023.1088900","DOI":"10.3389\/fphar.2023.1088900"},{"key":"3294_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40264-017-0528-z","volume":"40","author":"N Parameswaran Nair","year":"2017","unstructured":"Parameswaran Nair N, Chalmers L, Bereznicki BJ et al (2017) Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 40:597\u2013606. https:\/\/doi.org\/10.1007\/s40264-017-0528-z","journal-title":"Drug Saf"},{"key":"3294_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","volume":"72","author":"C Pedr\u00f3s","year":"2016","unstructured":"Pedr\u00f3s C, Formiga F, Corbella X, Arnau JM (2016) Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features. Eur J Clin Pharmacol 72:219\u2013226. https:\/\/doi.org\/10.1007\/s00228-015-1974-0","journal-title":"Eur J Clin Pharmacol"},{"key":"3294_CR22","unstructured":"Schumock GT, Thornton JP (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27:538"},{"key":"3294_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cger.2012.01.002","volume":"28","author":"BM Shah","year":"2012","unstructured":"Shah BM, Hajjar ER (2012) Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 28:173\u2013186. https:\/\/doi.org\/10.1016\/j.cger.2012.01.002","journal-title":"Clin Geriatr Med"},{"key":"3294_CR24","unstructured":"Wetzel DM, Phillips MA (2018) Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds) 13th edn. Mc Graw Hill, New York, pp 987\u20131000"},{"key":"3294_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12877-021-02532-z","volume":"21","author":"L Zerah","year":"2021","unstructured":"Zerah L, Henrard S, Wilting I et al (2021) Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial. BMC Geriatr 21:571. https:\/\/doi.org\/10.1186\/s12877-021-02532-z","journal-title":"BMC Geriatr"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:03:41Z","timestamp":1738382621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3294"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03294-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4109383\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee of the Institute of Medical Sciences, Banaras Hindu University, with approval number Dean\/2015\u201316\/IEC\/411 (EC Reg. No. ECR\/526\/Inst\/UP\/2014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the individual participants or their legal guardians for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}